Literature DB >> 26651611

Differential Impact of Pulmonary Regurgitation on Patients With Surgically Repaired Pulmonary Stenosis Versus Tetralogy of Fallot.

Michael R Joynt1, Sunkyung Yu2, Adam L Dorfman3, Maryam Ghadimi Mahani4, Prachi P Agarwal5, Jimmy C Lu3.   

Abstract

Patients with repaired pulmonary stenosis (PS) or tetralogy of Fallot (TOF) both develop pulmonary regurgitation (PR) leading to right ventricular (RV) dilatation and dysfunction. We aimed to characterize differential effects of chronic PR in these populations. Patients with surgically repaired PS were matched 1:2 by age and PR fraction with patients with TOF. Patients with previous pulmonary valve replacement were excluded. Cardiovascular magnetic resonance data were compared; peak longitudinal and circumferential systolic strain by feature tracking were compared to evaluate differential contribution of the RV sinus and outflow tract, respectively. PS (n = 24, 41 ± 13 years old) and TOF (n = 47, 39 ± 13 years old) patients did not differ in RV end-diastolic volume (153 ± 45 vs 154 ± 45 ml/m(2), p = 0.99) or diastolic function. However, patients with PS had preserved RV ejection fraction (54.3 ± 4.4% vs 48.0 ± 7.1%, p <0.0001). Differences were greater in RV circumferential (-15.8 ± 3.3 vs -11.8 ± 3.4, p <0.0001) than longitudinal strain (-18.0 ± 3.8 vs -15.9 ± 3.8, p = 0.04), with particular decrease in the infundibulum (-17.4 ± 7.5 vs -6.8 ± 6.3, p <0.0001). Late gadolinium enhancement in the RV outflow tract was more frequent in patients with TOF (70.2% vs 45.8%, p = 0.001). In conclusion, surgical repair of PS leads to similar RV dilatation and diastolic dysfunction compared to patients with TOF, but differential effects on ventricular systolic function, largely related to differences in the outflow tract. With different patterns of scarring and ventricular remodeling, further study is needed to clarify whether criteria for pulmonary valve replacement in patients with PS should differ from those with TOF. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2015        PMID: 26651611     DOI: 10.1016/j.amjcard.2015.10.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

2.  Differences in Right Ventricular Physiologic Response to Chronic Volume Load in Patients with Repaired Pulmonary Atresia Intact Ventricular Septum/Critical Pulmonary Stenosis Versus Tetralogy of Fallot.

Authors:  Andrew L Cheng; Abraham M Kaslow; Jay D Pruetz; Jimmy C Lu; John C Wood; Jon A Detterich
Journal:  Pediatr Cardiol       Date:  2018-10-23       Impact factor: 1.655

Review 3.  Pulmonary Valve Regurgitation: Neither Interventional Nor Surgery Fits All.

Authors:  Antonio F Corno
Journal:  Front Pediatr       Date:  2018-06-07       Impact factor: 3.418

4.  Trifecta St. Jude medical® aortic valve in pulmonary position.

Authors:  Antonio F Corno; Alan G Dawson; Aidan P Bolger; Branco Mimic; Suhair O Shebani; Gregory J Skinner; Simone Speggiorin
Journal:  Nano Rev Exp       Date:  2017-05-01

5.  The applications and potential limitations of right ventricular volumes as surrogate marker in tetralogy of fallot.

Authors:  Alexander C Egbe; Keerthana Banala; Rahul Vojjini; Karim Osman; Arslan Afzal; Vaibhav Jain; Sahith Thotamgari; Naser M Ammash
Journal:  Int J Cardiol Heart Vasc       Date:  2019-11-14

6.  Computed tomography for evaluating right ventricle and pulmonary artery in pediatric tetralogy of Fallot: correlation with post-operative pulmonary regurgitation.

Authors:  Yue Gao; Zhi-Gang Yang; Ke Shi; Kai-Yue Diao; Hua-Yan Xu; Ying-Kun Guo
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.